Skip to main content
Log in

Inflammation

Publishing model:
Open access

Overview

Inflammation is a comprehensive resource for the latest international advances in experimental and clinical research on inflammation.

  • Covers acute and chronic inflammation, pharmacology, and cytotoxicology among other topics.
  • Publishes full-length scientific reports, short articles, and proceedings.
  • No page charges or fees for online color images.
  • High author satisfaction with 100% of surveyed authors likely to publish again.

 

Editor-in-Chief
  • Massimo Gadina

Journal metrics

Journal Impact Factor
5.0 (2024)
5-year Journal Impact Factor
5.0 (2024)
Submission to first decision (median)
2 days
Downloads
853.3k (2024)

Latest articles

Journal updates

  • Inflammation is now fully open access!

    We are excited to announce that Inflammation has now become a fully open access (OA) journal as of January 2025. This means that we will only be publishing articles as Open Access meaning content will be and freely available to readers worldwide, enabling the widest possible dissemination and reuse. 

Journal information

Electronic ISSN
1573-2576
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  7. CLOCKSS
  8. CNKI
  9. CNPIEC
  10. Chemical Abstracts Service (CAS)
  11. Current Contents/Life Sciences
  12. Derwent Drug File
  13. Dimensions
  14. EBSCO
  15. EMBASE
  16. EMBiology
  17. Google Scholar
  18. IFIS Publishing
  19. Japanese Science and Technology Agency (JST)
  20. Medline
  21. Meta
  22. Naver
  23. Norwegian Register for Scientific Journals and Series
  24. OCLC WorldCat Discovery Service
  25. Pathway Studio
  26. Portico
  27. ProQuest
  28. Reaxys
  29. SCImago
  30. SCOPUS
  31. Science Citation Index Expanded (SCIE)
  32. TD Net Discovery Service
  33. Wanfang
  34. eLibrary.ru

© Springer Science+Business Media, LLC, part of Springer Nature

Journal navigation